These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34927657)

  • 1. The influence of different carbonate ligands on the hydrolytic stability and reduction of platinum(IV) prodrugs.
    Chen S; Ng KY; Zhou Q; Yao H; Deng Z; Tse MK; Zhu G
    Dalton Trans; 2022 Jan; 51(3):885-897. PubMed ID: 34927657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
    Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
    Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Inertness to Hydrolysis of Platinum(IV) Prodrugs.
    Ritacco I; Mazzone G; Russo N; Sicilia E
    Inorg Chem; 2016 Feb; 55(4):1580-6. PubMed ID: 26812023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability, Reduction, and Cytotoxicity of Platinum(IV) Anticancer Prodrugs Bearing Carbamate Axial Ligands: Comparison with Their Carboxylate Analogues.
    Chen S; Yao H; Zhou Q; Tse MK; Gunawan YF; Zhu G
    Inorg Chem; 2020 Aug; 59(16):11676-11687. PubMed ID: 32799457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Arsenal of Pt
    Yempala T; Babu T; Karmakar S; Nemirovski A; Ishan M; Gandin V; Gibson D
    Angew Chem Int Ed Engl; 2019 Dec; 58(50):18218-18223. PubMed ID: 31599054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the stability of Pt(IV) pro-drugs with haloacetato ligands in the axial positions.
    Wexselblatt E; Raveendran R; Salameh S; Friedman-Ezra A; Yavin E; Gibson D
    Chemistry; 2015 Feb; 21(7):3108-14. PubMed ID: 25529335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pt(IV) complexes as prodrugs for cisplatin.
    Shi Y; Liu SA; Kerwood DJ; Goodisman J; Dabrowiak JC
    J Inorg Biochem; 2012 Feb; 107(1):6-14. PubMed ID: 22169035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multitargeted Platinum(IV) Anticancer Complexes Bearing Pyridinyl Ligands as Axial Leaving Groups.
    Zhou Q; Chen S; Xu Z; Liu G; Zhang S; Wang Z; Tse MK; Yiu SM; Zhu G
    Angew Chem Int Ed Engl; 2023 Apr; 62(18):e202302156. PubMed ID: 36878864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride.
    Xu Z; Chan HM; Li C; Wang Z; Tse MK; Tong Z; Zhu G
    Inorg Chem; 2018 Jul; 57(14):8227-8235. PubMed ID: 29943979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond mere DNA damage: Recent progress in platinum(IV) anticancer complexes containing multi-functional axial ligands.
    Deng Z; Zhu G
    Curr Opin Chem Biol; 2023 Jun; 74():102303. PubMed ID: 37075513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pt(IV) Complexes in the Search for Novel Platinum Prodrugs with Promising Activity.
    Aher S; Zhu J; Bhagat P; Borse L; Liu X
    Top Curr Chem (Cham); 2024 Feb; 382(1):6. PubMed ID: 38400859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macromolecular Pt(IV) Prodrugs from Poly(organo)phosphazenes.
    Henke H; Kryeziu K; Banfić J; Theiner S; Körner W; Brüggemann O; Berger W; Keppler BK; Heffeter P; Teasdale I
    Macromol Biosci; 2016 Aug; 16(8):1239-1249. PubMed ID: 27169668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
    Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end?
    Gibson D
    J Inorg Biochem; 2021 Apr; 217():111353. PubMed ID: 33477089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insertion of (Bioactive) Equatorial Ligands into Platinum(IV) Complexes.
    Kastner A; Schueffl H; Yassemipour PA; Keppler BK; Heffeter P; Kowol CR
    Angew Chem Int Ed Engl; 2023 Nov; 62(46):e202311468. PubMed ID: 37703130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions.
    Wexselblatt E; Yavin E; Gibson D
    Angew Chem Int Ed Engl; 2013 Jun; 52(23):6059-62. PubMed ID: 23686723
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Lee VEY; Lim ZC; Chew SL; Ang WH
    Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing platinum azido complexes by 14N and 15N NMR spectroscopy.
    Farrer NJ; Gierth P; Sadler PJ
    Chemistry; 2011 Oct; 17(43):12059-66. PubMed ID: 21922574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.